UW madison
UW School of Medicine and Public Health
Carbone Cancer Center

Larry Green, Ph.D.

Chief Executive Officer
Ablexis, LLC
464 Hill Street
San Francisco, CA 94114

I received a B.S. with honors in chemistry from the University of Kentucky, my Ph.D. in 1988 working in McArdle with Dr. William Dove at the UW-Madison, and conducted post-doctoral work at the University of Colorado-Boulder and Stanford University. I began my professional career at Cell Genesys in 1992 and was a scientific founder of its spin-out, Abgenix, serving in an executive leadership role at the time of Abgenix's $2.2 billion acquisition by Amgen in 2006. I am a co-inventor of Abgenix's (now Amgen's) XenoMouse® technology and led the successful design and creation of multiple enhancements to that technology platform. I am a globally-recognized expert in the development and use of transgenic mice for the discovery of human therapeutic antibodies. I am an inventor of more than 60 issued and pending U.S. patents on antibody discovery technologies, antibody development technologies and therapeutic product candidates. In 2008, I became CEO of Aliva Biopharmaceuticals, which in 2009 became a subsidiary of Ablexis.

Donate Now